BNGO News and Press, Bionano Genomics Inc. From 08/04/21

Bionano Genomics (NASDAQ:BNGO) shares rise nearly 4% post market after reporting second-quarter revenue that beat Wall Street estimates, helped by the momentum in the cytogenetics market. The company's chief executive officer Chris Stewart called the quarterly results "very pos...

Management is trying to introduce new technology to the medical research and diagnostic market. The potential is high, but the risks are too. There might be no market for Saphyr. The current cash balance is enough to sustain the company for nearly five years while pitching its tec...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bionano (NASDAQ: BNGO ) is a small life sciences company. Biotech companies use Bionano’s Saphyr system for researching DNA and to diagnose illnesses caused by genetics. Up until recently, Bionano has had diffi...

SAN DIEGO, July 28, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, August 4, 2021 at 4:30 p.m. Eastern Time to report financial results for the second quarter ended June 30, 2021 and to highli...

SAN DIEGO, July 27, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a record number of optical genome mapping (OGM) presentations scheduled to appear at the annual Cancer Genomics Consortium (CGC) meeting being held from August 1 - 4, 2021. Across this four-da...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Based on my financial analysis, I would not touch Bionano Genomics (NASDAQ: BNGO ) right now. I would run fast and far away from BNGO stock. But why? There are several reasons, and they all have to do with fundamental...

SAN DIEGO, July 19, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announces a summary of the results obtained by the University Hospitals Leuven, Belgium with optical genome mapping (OGM) with Bionano’s Saphyr ® system. An assay was developed for whole genom...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bionano Genomics (NASDAQ: BNGO ) stock, along with most other meme stocks, has been tumbling in recent weeks. But unlike most other meme names, Bionano has a highly disruptive product, and its shares are tremendously ...

Diagnostics stocks hit a rough patch this week. Shares of Bionano Genomics (NASDAQ: BNGO) were down 13.5% for the week as of the market close on Thursday. Invitae (NYSE: NVTA) stock was off by 12% over the last four days, while Opko Health (NASDAQ: OPK) shares have t...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips With meme stocks starting to tumble and Wall Street becoming much more skeptical about Clover Health (NASDAQ: CLOV ), the outlook of CLOV stock has deteriorated meaningfully in recent weeks. Source: Shutterstock ...